449 related articles for article (PubMed ID: 16875847)
1. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
[TBL] [Abstract][Full Text] [Related]
2. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
[TBL] [Abstract][Full Text] [Related]
3. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
4. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
[TBL] [Abstract][Full Text] [Related]
5. Regional specificity of brain atrophy in Huntington's disease.
Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
[TBL] [Abstract][Full Text] [Related]
6. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
7. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
8. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
9. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
10. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI.
Kassubek J; Unrath A; Huppertz HJ; Lulé D; Ethofer T; Sperfeld AD; Ludolph AC
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):213-20. PubMed ID: 16319024
[TBL] [Abstract][Full Text] [Related]
11. Early grey matter changes in structural covariance networks in Huntington's disease.
Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
[TBL] [Abstract][Full Text] [Related]
12. Variation of selective gray and white matter atrophy in Huntington's disease.
Jech R; Klempír J; Vymazal J; Zidovská J; Klempírová O; Růzicka E; Roth J
Mov Disord; 2007 Sep; 22(12):1783-9. PubMed ID: 17579363
[TBL] [Abstract][Full Text] [Related]
13. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
[TBL] [Abstract][Full Text] [Related]
14. Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry.
Specht K; Minnerop M; Müller-Hübenthal J; Klockgether T
Neuroimage; 2005 Mar; 25(1):287-93. PubMed ID: 15734363
[TBL] [Abstract][Full Text] [Related]
15. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
[TBL] [Abstract][Full Text] [Related]
16. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
17. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
[TBL] [Abstract][Full Text] [Related]
18. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
[TBL] [Abstract][Full Text] [Related]
19. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters.
Minnerop M; Specht K; Ruhlmann J; Schimke N; Abele M; Weyer A; Wüllner U; Klockgether T
Neuroimage; 2007 Jul; 36(4):1086-95. PubMed ID: 17512219
[TBL] [Abstract][Full Text] [Related]
20. Application of an automated voxel-based morphometry technique to assess regional gray and white matter brain atrophy in a canine model of aging.
Tapp PD; Head K; Head E; Milgram NW; Muggenburg BA; Su MY
Neuroimage; 2006 Jan; 29(1):234-44. PubMed ID: 16275022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]